Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Flare V10 offers a range of new functionalities for every computational or medicinal chemist
    12 February 2025

    Cresset releases Flare™ V10, the latest update to its agile ligand and structure-based drug design platform, featuring significant scientific enhancements for computational and medicinal chemists

    12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists. ...

    Seth Benson, CFO, Nuclera
    24 February 2025

    Nuclera appoints Seth Benson as Chief Financial Officer

    Appointment to drive commercial growth of eProtein Discovery and support strategic expansion ...

    Design team
    21 February 2025

    A design for Life Science: scoping out your cleanroom construction project with the Guardtech Group

    Suffolk contamination control specialists have fleshed out some critical early stages advice for clients looking to start a new cleanroom build ...

    Ben Porebski and Philipp Holliger
    21 February 2025

    Sortera Bio spins out of the MRC Laboratory of Molecular Biology to pioneer new frontiers in biologics discovery

    New UK-based biotechnology company launched to realise therapeutic potential of deep screening technology developed at the Medical Research Council Laboratory of Molecular Biology (MRC LMB). ...

    Mike Hampton, Chief Commercial Officer at Sapio Sciences
    18 February 2025

    Sapio Sciences expands leadership team to drive growth

    Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership ...

    Personalising the Patient Experience
    18 February 2025

    Personalising the patient experience

    Co-authored by Jose Maria (Chema) Guido Avila, SanofiIn the healthcare industry, personalisation is often touted as the key to enhancing patient and healthcare provider (HCP) engagement. Yet, in practice, we frequently fall short. We collect data, conduct research, and generate profiles...

    Professor Bo Wang,  Senior Advisor, Shift Bioscience	Lucas Camillo,  Head of Machine Learning, Shift Bioscience
    18 February 2025

    Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology

    Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior AdvisorExpansion into global AI hub to accelerate growth of IP portfolio and progress toward key technical milestones Cambridge, UK, and Toronto, Canada, 18 Febr...

    William Kullback, NED, Nuclera
    18 February 2025

    Nuclera appoints William J. Kullback as Non-Executive Director

    Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc.Cambridge, UK, 18 February 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop ePr...

    rom left Jo Igoe from University of Cambridge Estates Division, Mayor Dr Nik Johnson, Dr Diarmuid O’Brien, Pro Vice Chancellor for Innovation and Matt Johnson, Head of Development for North West Cambridge, University of Cambridge.
    14 February 2025

    Mayor Dr Nik Johnson visits Cambridge West to see innovation in action

    Mayor of Cambridgeshire and Peterborough Dr Nik Johnson visited Cambridge West to see first-hand how it is evolving.Cambridge West combines academia, research, and entrepreneurship, co-locating world-class academic talent with knowledge-intensive businesses. Once complete, the campus is...

    Title image for Stephen Bruyant-Langer
    14 February 2025

    Why you’re dissatisfied with life (and what to do about it)

    Møller Institute associate, Stephen Bruyant-Langer, explores the issue of work-life-balance and the challenge high achieving individuals have in finding sustainable happiness. Stephen as a top executive coach, headhunter, economist, marketeer, author, lecturer, facilitator and keynote...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 112
    • Page 113
    • Current page 114
    • Page 115
    • Page 116
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS